3Rasche FM,Keller F,von Müller L,et al.Mycophenolic acid therapy af-ter cyclophosphamide pulses in progressive IgA nephropathy[].Journal of Nephrology.2006
4MacKinnon M,Shurraw S,Akbari A,et al.Combination therapy with an angiotensin receptor blockers and an ACE inhibitor in proteinuria renal disease:a systematic review of the efficacy and safety data[].American Journal of Kidney Diseases.2006
5Yamamoto R,Nagasawa Y,Shoji T,et al.Cigarette smokingand progression of IgA nephropathy[].American Journal of Kidney Diseases.2010
6Hamazaki T,Tateno S,Shishido H.Eicosapentaenoic acid and IgA nephropathy[].The Lancet.1984
4Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China [ J ]. Am J Nephrol, 2008,28( 1 ) : 1 - 7.
5Dillon JJ. Treating IgA nephropathy[J]. J Am Soc Nephrol,2001, 12:84.
6Green S, Watanbe K, Braatz-Trulson, et al. Inhibition of dihydroorotate Dehydrogenease by the immunosuppressive agent leflunomide[J ]. Biochem Pharmacol, 1995,50 : 861 - 867.
7Xu X,Williams JW,Bremer EG,et al. Inhibition of pretein tyrosine Phosphorylation in T cells by a novel immunosuppressive agent leflunomide[ J ]. J BiolChem, 1995,270 : 12398 - 1203.
3Donadio JV,Grande JP.Ig, A nephropathy[J].N EngI J Med,2002(347):738-748.
4Li PKT,Leung CB,Chow KM,et al.Hong Kong study using Valsartan in I- gAN(HKVIN)-A double-blind randomized placebo-con-trolled study[J]. Am J Kidney Dis,2006,47(5):751-760.
5Coppo R,Peruzzi L, Amore A,et al.IgACE:a placebo-eontrolled,rand- omized trial of angotensin-converting enzyme inhibitors in childr- en and young people with IgAN and moderate proteinuria[J].J Am Soc Nephrol,2007,18(6): 1880-1888.
6Yamamoto R,Nagasawa Y,Shoji T,et al.Cigarette smoking and prog- ression of IgA nephropathy[J].Am J Kidney Dis,2010,56(2):313-324.
7Pozzi C,Andrulli S,Del VL,et al.Corticosteroid effectiveness in IgA nephropathy:long-term results of a randomized.controlled trial[J].J Am Soc Nephrol,2004,15(1):157-163.
8KDIGOKGW G.KDIGO Clinical Practice Guideline for Glomer u- lonephritis[J].Kid Int Suppl,20'12,2(2):259-274.
9Tang SC,Tang AW,Wong SS,et al.Long-term Study of mycophenola- te mofetil treatment in IgA nephropathy[J].Kidney Int,2010,77(6): 543-549.
10Liu XW,Linm,Xu Gs,et al.Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immun- oglobulin A nephropathy manifesting with nephritic syndrome[J].Int J Clin pharmacol Ther,2010,48(8):509-513.
